Refractory Hodgkin lymphoma: time for targeted therapies?

被引：1
|
作者：
Brice, Pauline [1 ]
机构：
[1] Hop St Louis, Paris, France
来源：
BLOOD | 2018年 / 131卷 / 11期
关键词：
BRENTUXIMAB VEDOTIN; PHASE-II; SINGLE;
D O I：
10.1182/blood-2017-12-824136
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
With the use of targeted therapies in classical Hodgkin lymphoma (HL), the paradigm of salvage chemotherapy followed by autotransplant may have changed. In this issue of Blood, Herrera et al report positive results using targeted therapy for salvage treatment before autotransplantation.(1)
引用
收藏
页码：1156 / 1157
页数：4
相关论文
共 50 条
  • [31] Advances in CD30-and PD-1-targeted therapies for classical Hodgkin lymphoma
    Wang, Yucai
    Nowakowski, Grzegorz S.
    Wang, Michael L.
    Ansell, Stephen M.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [32] Targeted treatment approaches in Hodgkin lymphoma
    Janz, M.
    Stuhmer, T.
    Vassilev, L. T.
    Doerken, B.
    Bargou, R. C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 14 - 14
  • [33] A review of pathobiology and therapies for classic Hodgkin lymphoma
    Khan, Maliha
    Hagemeister, Fredrick
    Wang, Michael
    Ahmed, Sairah
    BLOOD REVIEWS, 2022, 55
  • [34] New therapies in non-Hodgkin lymphoma
    Novelli, Silvana
    Sierra, Jorge
    Briones, Javier
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (03) : 349 - 359
  • [35] Management of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the Era of Targeted Therapies
    Michael Rainone
    Tanya Siddiqi
    Current Hematologic Malignancy Reports, 2022, 17 : 39 - 45
  • [36] Management of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the Era of Targeted Therapies
    Rainone, Michael
    Siddiqi, Tanya
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2022, 17 (01) : 39 - 45
  • [37] Novel therapies for non-Hodgkin Lymphoma
    Vose, Julie M.
    ANNALS OF ONCOLOGY, 2015, 26 : 17 - 17
  • [38] Lymphoma in 'India' at the Dawn of Targeted Therapies
    Kapoor, Rajan
    Kumar, Rajiv
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2018, 34 (03) : 385 - 386
  • [39] Lymphoma in ‘India’ at the Dawn of Targeted Therapies
    Rajan Kapoor
    Rajiv Kumar
    Indian Journal of Hematology and Blood Transfusion, 2018, 34 : 385 - 386
  • [40] Targeted and novel therapies for non-Hodgkin lymphoma: the role of radioimmunotherapy and haemopoietic stem cell transplantation
    Pavone, V.
    De Francesco, R.
    Mele, A.
    Rana, A.
    Greco, G.
    Frusciante, V.
    Varraso, A.
    Del Casale, C.
    Dicembrino, F.
    Tabacco, P.
    Caputo, M.
    Ostuni, A.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S124 - S124
12345